Welcome to the website of the ERA-CVD consortium ENDLESS.
You will find useful information about the aim of our project, members and newest results.
The scientific community has faced an impressive shift in incidence and clinical presentation of atherosclerotic disease over the last two decades. Mortality rates due to myocardial infarctions (MI) have decreased by nearly 50% and clinical presentation deviated away from a predominance of STEMI towards NSTEMI.
In line with the shift in clinical presentation there has been a significant change in the underlying pathology of symptomatic atherosclerotic lesions that is gradually shifting from the lipid rich unstable plaque towards more stable, fibrous and less inflammatory plaques.
This paradigm shift mandates uncovering the mechanisms that accelerate a thrombotic event on top of a stable plaque. The endothelial cell plays a crucial role in leucocyte and platelet adhesion that promote luminal thrombosis, even in the absence of plaque rupture.
ENDLESS will unravel mechanisms that lead to endothelial desquamation or transdifferentiation (EndoMT) and explain the thrombotic event that is superimposed on a stable non-ruptured plaque.
We will study how coronary artery disease susceptibility genes affect endothelial cell transcription and function. In addition, we will assess the role of microparticle formation in the mechanisms that disrupt the endothelial layer (erosion) and gives rise to a thrombotic event. Analyses will be executed in sex-stratified manner as thrombus on top of stable plaques has been described to be more prevalent in women.
Ultimately, this may lead to new mechanisms pointing towards therapy to preserve a healthy endothelium on top on an intact stable plaque.
To unravel which EC-specific mechanisms provoke thrombus on a stable fibrous atherosclerotic lesion, in a sex-specific manner.
1. Prioritizing causal genes expressed in endothelium
2. Data harmonization
Unravel the functional relevance of selected EC-specific candidate genes for CAD and large artery stroke in endothelial activation, endothelial to
mesenchymal transition (EndoMT), endothelial-leucocyte interaction and EC apoptosis.
Assess if endogenous microparticles influence the expression of prioritized candidate genes and subsequent
leucocyte and platelet adhesion on an endo-thelial layer and of a stable plaque.
Strictly necessary cookies guarantee functions without which this website would not function as intended. As a result these cookies cannot be deactivated. These cookies are used exclusively by this website and are therefore first party cookies. This means that all information stored in the cookies will be returned to this website.
Functional cookies enable this website to provide you with certain functions and to store information already provided (such as registered name or language selection) in order to offer you improved and more personalized functions.
Performance cookies gather information on how a web page is used. We use them to better understand how our web pages are used in order to improve their appeal, content and functionality.
Marketing / Third Party Cookies originate from external advertising companies (among others) and are used to gather information about the websites visited by you, in order to e.g. create targeted advertising for you.